Parameters of Research into the Depressive States

References

• Abramson D. I., Schloven N., Katzenstein K. H. Peripheral blood flow in schizophrenia and other abnormal mental states. Arch. Neurol. Psychiat. 1941; 45: 973
   Google Scholar
• Ackner B., Pampiglione G. Discussion on physiological measurements of 'emotional tension'. Proc. Roy. Soc. Med. 1958; 51: 76
   Google Scholar
• Ackner B., Pampiglione G. An evaluation of the sedation threshold test. J. Psychosom. Res. 1959; 3: 271
   Google Scholar
• Altschule M. D. Bodily Physiology in Mental and Emotional Disorders. Grune and Stratton, New York 1953
   Google Scholar
• Altschule M. D., Tillotson K. J. Effects of electro-convulsive therapy on diuretic response to water in psychotic patients. Arch. Neurol. Psychiat. 1949; 61: 188
   Google Scholar
• Altschule M. D., Ascoli I., Tillotson K. J. Extracellular fluid and plasma volumes in depressed patients given electric shock therapy. Arch. Neurol. Psychiat. 1949; 62: 618
   Google Scholar
• Amdisen A. The methacholine test in endogenous depression treated with imipramine (Tofranil). Acta Psychiat. Scand. Suppl. 1961; 162: 127
   Google Scholar
• Anderson W. McC., Dawson J. The clinical manifestations of depressive illness with abnormal acetyl methyl carbinol metabolism. J. Ment. Sci. 1962; 108: 80
   Google Scholar
• Anderson W. McC., Dawson J. Verbally retarded depression and sodium metabolism. Brit. J. Psychiat. 1963; 109: 225
   Google Scholar
• Anderson W. McC., Dawson J. The variability of plasma 17-hydroxycorticosteroids — levels in affective illness and schizophrenia. J. Psychosom. Res. 1965; 9: 237
   Google Scholar
• Anderson W. McC., Dawson J., Margerison J. H. Serial biochemical, clinical and electroencepholographic studies in affective illness. Clin. Sci. 1964; 26: 323
   Google Scholar
• Angst J. A clinical analysis of the effects of Tofranil in depression. Psychopharmacologia 1961; 2: 381
   PubMedGoogle Scholar
• Angst J. Antidepressive Effekt und genetische Factoren. Arzneim. Forsch. 1964; 14: 496
   PubMedGoogle Scholar
• Ansani A. La gliceima differenziale capil-lare-venosci nei maniaco-depressivi in annesto psicomotorico. Ann. osp. psychiat. di Perugia 1938; 30: 33
   Google Scholar
• Ashcroft G. W., Sharman D. F. 5-hydroxyindoles in human cerebrospinal fluids. Nature (Land.) 1960; 186: 1050
   PubMedGoogle Scholar
• Ashcroft G. W., Crawford T. B. B., Eccleston D., Sharman D. F., MacDougall E. J., Stanton J. B., Binns J. K. 5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. Lancet 1966; 2: 1049
   PubMed Web of Science ®Google Scholar
• Axelrod J., Inscoe J. K. The uptake and binding of circulating serotonin and the effect of drugs. J. Pharmacol. Exp. Therap. 1963; 141: 161
   PubMed Web of Science ®Google Scholar
• Axelrod J., Whitby L. G., Hertting G. Effect of psychotropic drugs on the uptake of H3-norepinephrine by tissues. Science 1961; 133: 383
   PubMed Web of Science ®Google Scholar
• Bagg C. E., Crookes T. G. Palmar digital sweating in women suffering from depression. Brit. J. Psychiat. 1966; 112: 1251
   Google Scholar
• Baruk H., Melzer R., Jaubert M. F. Ann. Med. Psychol. 1950; 108: 243
   Google Scholar
• Bergsman A. The urinary excretion of adrenaline and noradrenaline in some mental diseases. Acta Psychiat. et Neurol. Seand. 1959; Vol. 34, Suppl. 133
   Google Scholar
• Blumberg A. G. Reproductibility of the mecholyl test. Psychosom. Med. 1960; 22: 32
   Google Scholar
• Blumberg A. C., Cohen L., Miller J. S. A. The relation of mecholyl-induced hypotension to the classification of psychiatric patients and its prognostic significance with electroshock therapy. J. Hillside Hosp. 1956; 5: 216
   Google Scholar
• Board F., Persky H., Hamburg D. A. Psychological stress and endocrine functions. Psychosom. Med. 1956; 28: 32
   Google Scholar
• Board F., Wadeson R., Persky H. Depressive affect and endocrine functions. Arch. Neurol. Psychiat. 1957; 78: 612
   PubMedGoogle Scholar
• Bojanovsky J. The use of thiopental in a differential diagnosis of endogenous and psychogenic depression. Activatas Nervosa Superior 1965; 7: 291
   Google Scholar
• Bourdreau D. Evaluation of the sedation threshold. Arch. Neurol. Psychiat. 1958; 80: 771
   Google Scholar
• Bowman K. M., Miller E. R., Darley M. E., Simon A., Mayer B. F. Thyroid function in mental disease. J. Nerv. Ment. Dis. 1950; 112: 404
   Google Scholar
• Brandrup E., Randrup A. A controlled investigation of plasma lipids in manic-depressives. Brit. J. Psychiat. 1967; 113: 987
   Google Scholar
• Bridges P. K., Jones M. T. The dlurnal rhythm of plasma cortisol concentration in depression. Brit. J. Psychiat. 1966; 112: 1257
   PubMed Web of Science ®Google Scholar
• Bridges P. K., Jones M. T. Personality, physique, and the adrenocortical response to psychological stress. Brit. J. Psychiat. 1967; 113: 601
   Google Scholar
• Brockhausen K. Uber erbbiologische Untersuchungen involutiver Psychosen, insbesondere über erstmalig in der Involution auftretende reine Melancholien. Ztschr. f.d. ges. Neurol. u Psychiat. 1937; 157: 17
   Google Scholar
• Brody E. B. Psychologic tension and blood iodine levels in psychiatric patients without evidence of thyroid disease. Psychosom. Med. 1949; 11: 70
   Google Scholar
• Brooksbank B. W. L., Coppen A. Plasma 11-hydroxycorticosteroids in affective disorders. Brit. J. Psychiat. 1967; 113: 395
   Google Scholar
• Brothers A. V., Bennett A. E. The Funkenstein test as a guide to treatment in the neuroses and psychoses. Dis. Nerv. Syst. 1954; 15: 3
   Google Scholar
• Brown F. W. Heredity in psyehoneurosis. Proc. Row. Soc. Med. 1942; 35: 785
   PubMedGoogle Scholar
• Brown D. G., Hullin R. P., Roberts J. M. Fluid distribution and the response of depression to E.C.T. and imipramine. Brit. J. Psychiat. 1963; 109: 395
   Google Scholar
• Bryson R. W., Martin D. F. 17-ketosteroid excretion in a case of manic-depressive psychosis. Lancet 1954; 2: 365
   Google Scholar
• Bunney W. E., Jr., Mason J. W., Hamburg D. A. Correlations between behavioural variables and urinary 17-hydroxycorticosteroids in depressed patients. Psychosom. Med. 1965; 27: 299
   PubMedGoogle Scholar
• Burgermeister J. J., Dick P., Garrone G., Guggisberg M., Tissot R. Excrètion urinaire de l'acide 5-hydroxyindoleacetique (5-HIAA) chez 150 malades atteints de syndrome dèpressif et d'agitation maniaque. Presse Med. 1963; 71: 1116
   Google Scholar
• Busfield B. L., Wechsler H., Barnum W. J. salivation in depression. Arch. Gen. Psychiat., 4: 10
   Google Scholar
• Busfield B. L., Wechsler H. Salivation rate: a physiologic correlate of improvement in hospitalised depressed patients treated with three antidepressant medications. Psychosom. Med. 1962; 24: 337
   Google Scholar
• Busfield B. L., Wechsler H., Barnum W. J. A physiological correlate of diagnosis and treatment outcome in depression. Third World Congress of Psychiatry Proceedings. 1961; 1367
   Google Scholar
• Busson H., Essen K. W. The galvanic skin reflex in endogenous depression. Monatschr. Psychiat. u Neurol. 1935; 90: 326
   Google Scholar
• Cade J. F. J. The relation between recovery and plasma potassium levels in manic states. Med. J. Aust. 1962; 2: 911
   Web of Science ®Google Scholar
• Cade J. F. J. A significant elevation of plasma magnesium levels in schizophrenia and depressive states. Med. J. Aust. 1964a; 1: 195
   PubMedGoogle Scholar
• Cade J. F. J. The biochemistry of schizophrenic and affective psychoses. Med. J. Aust. 1964b; 2: 878
   Google Scholar
• Cade J. F. J. The metabolism of melancholia. Aust. N.Z. J. Psychiat. 1967; 1: 23
   Web of Science ®Google Scholar
• Carney M. W. P., Roth M., Garside R. F. The diagnosis of depressive syndromes and the prediction of E.C.T. response. Brit. J. Psychiat. 1965; 111: 659
   PubMed Web of Science ®Google Scholar
• Cazzullo C. L., Mangoni A., Mascherpa G. Tryptophan metabolism in affective psychoses. Brit. J. Psychiat. 1966; 112: 157
   Google Scholar
• Claridge G. S. Personality and Arousal: A Psychophysiological Study of Psychiatric Disorder. Pergamon Press, Oxford 1967
   Google Scholar
• Claridge G. S., Herrington R. N. Sedation threshold, personality and the theory of neurosis. J. Ment. Sci. 1960; 106: 1568
   PubMed Web of Science ®Google Scholar
• Claridge G. S., Herrington R. N. Excitation inhibition and the theory of neurosis: a study of the sedation threshold. Experiments With Drugs, H. G. Eysenck. Pergamon Press, Oxford 1962
   Google Scholar
• Cochran B., Marbach E. P. Some acute and chronic biochemical responses to electroconvulsive therapy. Recent Advances in Biological Psychiatry, J. Wortis. Plenum Press, New York 1962; 4: 154
   Google Scholar
• Consbruch V., Faust C. Vergleichende Längsschnittbetrachtung der Serumeiweissverhältnisse bei exogenen traumatischen Psychosen und bei endogen Psychosen unter der Behandlung mit Reserpin, Iminodibenzylderivat und Phenothiazinen. Arch. Psychiat. Nervenkr. 1958; 197: 279
   Google Scholar
• Consbruch V., Faust C. Vergleichende Längsschnittbetrachtung der Serumeiweissverhältnisse bei exogenen traumatischen Psychosen und bei endogenen Psychosen unter der Behandlung mit Reserpin, Iminodibenzylderivat und Phenothiazinen. Confin. Neurol. 1958; 18: 280
   Google Scholar
• Constantinidis J., Faban Ch. H., Garrone G. Examens biologiques dans les syndromes melancoliques. Praxis 1962; 51: 590
   Google Scholar
• Constantinidis J., Dejaiffe G., Tissot R. Excretion de l'acide 5-hydroxyindoleacetique (5-HIAA) de 20 psychoses atypiques de type cycloide. Psychopharmacologia 1965; 7: 266
   Google Scholar
• Coppen A. Abnormality of the blood-cerebrospinal fluid barrier of patients suffering from a depressive illness. J. Neurol. Neurosurg. Psychiat. 1960; 23: 156
   Google Scholar
• Coppen A. The biochemistry of affective disorders. Brit. J. Psychiat. 1967; 113: 1237
   PubMed Web of Science ®Google Scholar
• Coppen A., Shaw D. M. Mineral metabolism in melancholia. Brit. Med. J. 1963; 2: 1439
   PubMedGoogle Scholar
• Coppen A., Shaw D. M., Farrell J. P. Potentiation of the antidepressive effect of a monoamine oxidase inhibitor by tryptophan. Lancet 1963; 1: 79
   PubMed Web of Science ®Google Scholar
• Coppen A., Shaw D. M., Mangani A. Total exchangeable sodium in depressive illness. Brit. Med. J. 1962; 2: 295
   Google Scholar
• Coppen A., Julian T., Fry D. E., Marks V. Body build and urinary steroid excretion in mental illness. Brit. J. Psychiat. 1967; 113: 269
   Google Scholar
• Coppen A., Shaw D. M., Malleson A., Eccleston E., Grundy G. Tryptamine metabolism in depression. Brit. J. Psychiat. 1965; 111: 993
   PubMedGoogle Scholar
• Crammer J. L. Periodic psychosis. Brit. Med. J. 1959; 1: 545
   Google Scholar
• Crammer J. L. Water and sodium in two psychotics. Lancet 1959; 1: 1122
   Google Scholar
• Cropley A. J., Weckowicz T. E. The dimensionality of clinical depression. Aust. J. Psychol. 1966; 18: 18
   Web of Science ®Google Scholar
• De Fonseca A. F. Affective equivalents. Brit. J. Psychiat. 1963; 109: 464
   PubMed Web of Science ®Google Scholar
• Davies B. M. The methacholine test in depressive states. Arch. Gen. Psychiat. 1960; 3: 14
   Google Scholar
• Davies B. M., Gurland J. B. Salivary secretion in depressive illness. J. Psychosom. Res. 1961; 5: 269
   Google Scholar
• Davies B. M., Palmai G. Salivary and blood pressure responses to methacholine in depressive illness. Brit. J. Psychiat. 1964; 110: 594
   PubMedGoogle Scholar
• Davis P. A. Electroencephalograms of manic-depressive patients. Amer. J. Psychiat. 1941; 98: 430
   Google Scholar
• Davis P. A. A comparative study of the E.C.G's of schizophrenic and manic-depressive patients. Amer. J. Psychiat. 1942; 99: 210
   Google Scholar
• Davis P. A., Davies H. The electroencephalograms of psychotic patients. Amer. J. Psychiat. 1939; 95: 1007
   Google Scholar
• Dawson J., Hullin R. P., Crockett B. M. Metabolic variations in manic-depressive psychosis. J. Ment. Sci. 1956; 102: 168
   Google Scholar
• Dawson J., Hullin R. P., Pool A. Variations in the blood levels of acetoin and butane — 2:3 — diol in normal individuals and mental patients. J. Ment. Sci. 1954; 100: 536
   Google Scholar
• Dencker S. J., Malm V., Roos B. E., Werdinius B. Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania. J. Neurochem. 1966; 13: 1545
   PubMed Web of Science ®Google Scholar
• Dewhurst W. G., Pare C. M. B. A clinical and biochemical study of monoamine oxidase inhibition in depressed patients. II. 5-hydroxytryptamine tolerance before and after nialimide. J. Ment. Sci. 1961; 107: 244
   Google Scholar
• Doig R. J., Mummery R. V., Wills M. R., Elkes A. Plasma cortisol levels in depression. Brit. J. Psychiat. 1966; 112: 1263
   PubMed Web of Science ®Google Scholar
• Easierday O. D., Featherstone R. M., Gottlieb J. S., Nusser M. L., Hagg R. V. Blood glutathione, lactic acid, and pyruvic acid relationships in schizophrenia. Arch. Neurol, Psyehiat. 1952; 68: 48
   Google Scholar
• Elsasser G. Die Nachkommen geisteskranker Elternpaare. Grune und Stration, Stuttgart 1952
   Google Scholar
• Engel G. L., Reichsman F., Segal H. A study of an infant with gastric fistula. Psychosom. Med. 1956; 18: 374
   PubMed Web of Science ®Google Scholar
• Evans D. A. P. Individual variations of drug metabolism as a factor in drug toxicity. Ann. N.Y. Acad. Sci. 1965; 123: 178
   PubMed Web of Science ®Google Scholar
• Evans D. A. P., Davison K., Pratt R. T. C. The influence of acetylator phenotype on the effects of treating depression with phenelzine. Clin. Pharmacol. Therap. 1965; 6: 430
   Google Scholar
• Evans D. A. P., Manley K. A., McKusick V. A. Human isoniazid metabolism — a genetically-determined phenomenon. Brit. Med. J. 1960; 2: 485
   PubMed Web of Science ®Google Scholar
• Eysenck H. J. Parotid gland secretion in affective mental disorders. J. Ment. Sci. 1944; 90: 595
   Google Scholar
• Eysenck H. J. Dimensions of Personality. Routledge and Kegan Paul, London 1947
   Google Scholar
• Eysenck H. J. A dynamic theory of anxiety and hysteria. J. Ment. Sci. 1955; 101: 28
   PubMed Web of Science ®Google Scholar
• Fair C. B., Lueders C. W., Bond E. D. Studies of gastric secretion and motility in mental patients. Amer. J. Psychiat. 1925; 5: 93
   Google Scholar
• Fawcett J. A., Bunney W. E., Jr. Pituitary adrenal function and depression. Arch. Gen. Psychiat. 1967; 16: 517
   PubMed Web of Science ®Google Scholar
• Feldstein A., Hoagland H., Wong K. K., Oktem M. R., Freeman H. MAO activity in relation to depression. Amer. J. Psychiat. 1965; 120: 1192
   Google Scholar
• Ferguson H. C., Bartram A. C. G., Fowlie H. C., Cathro D. M., Birchall K., Mitchell F. L. A preliminary investigation of steroid excretion in depressed patients before and after electroconvulsive therapy. Acta Endocrinol. Kbh. 1964; 47: 58
   PubMedGoogle Scholar
• Fessell W. J. Autoimmunity and mental illness. Arch. Gen. Psychiat. 1962; 6: 320
   Google Scholar
• Fessell W. J. Blood proteins in functional psychoses. Arch. Gen. Psychiat. 1962; 6: 132
   Google Scholar
• Fink M. Electroencephalographic and behavioural effects of Tofranil. Canad. Psychiat. Ass. J. 1959; 166, Supplement
   Google Scholar
• Fink M., Kuhn R. L. Relation of electroencephalographic delta activity to behavioural response in electroshock. Arch. Neurol. Psychiat. 1957; 78: 516
   Google Scholar
• Finley K. H. On the occurrence of rapid frequency potential changes in the human electroencephalogram. Amer. J. Psychiat. 1944; 101: 194
   Google Scholar
• Fisk A. A., Chanutin A., Klingman W. O. Lipids and proteins of plasma in patients with diseases of the nervous system. Arch. Neurol. Psychiat. 1952; 67: 332
   Google Scholar
• Flach F. F. Calcium metabolism in states of depression. Brit. J. Psychiat. 1964; 110: 588
   Google Scholar
• Flach F. F. Psychopharmacologic and metabolic studies on states of depression. Fourth World Congress of Psychiatry. 1966; 184, Excerpta Medica: International Congress Series No. 117
   Google Scholar
• Flach F. F., Burrell C. D., Liang E. Alterations in calcium metabolism in depressed patients receiving imipramine. Proceedings of the Third World Congress of Psychiatry. Montreal, Canada 1961; 1409
   Google Scholar
• Flach F. F., Liang E., Stokes P. E. The effects of electric convulsive treatment on nitrogen, calcium and phosphorus metabolism in psychiatric patients. J. Ment. Sci. 1960; 106: 638
   Google Scholar
• Fotherby K., Asheroft G. W., Affleck J. W., Forrest A. D. Studies on sodium transfer and 5-hydroxyindoles in depressive illness. J. Neurol. Neurosurg. Psychiat. 1962; 26: 71
   Google Scholar
• Freeman H., Zaborenko R. N. Relation of changes in carbohydrate metabolism to psychotic states. Arch. Neurol. Psychiat. 1949; 61: 569
   Google Scholar
• Friedman A. S., Cowitz B., Cohen H. W., Granick S. Syndromes and themes of psychotic depression. Arch. Gen. Psychiat. 1963; 9: 102
   Google Scholar
• Friend D. G. The metabolism of dihydroxy-phenylalanine in man before and after administration of psychotropic drugs. Ann. N.Y. Acad. Sci. 1962; 96: 152
   Google Scholar
• Funkenstein D. H., Greenblatt M., Solomon H. C. Autonomic nervous system changes following electric shock treatment. J. Nerv. Ment. Dis. 1948; 108: 409
   PubMed Web of Science ®Google Scholar
• Gellhorn E., Miller A. D. Methacholine and noradrenaline tests. Arch. Gen. Psychiat. 1961; 4: 371
   Google Scholar
• Geocaris K. H., Kooiker J. E. Blood pressure responses of chronic schizophrenic patients to epinephrine and mecholyl. Amer. J. Psychiat. 1956; 112: 808
   Google Scholar
• Gibbons J. L. Total body sodium and potassium in depressive illness. Clin. Sci. 1960; 19: 133
   Google Scholar
• Gibbons J. L. Cortisol secretion rate in depressive illness. Arch. Gen. Psychiat. 1964; 10: 572
   PubMed Web of Science ®Google Scholar
• Gibbons J. L. The secretion rate of corticosterone in depressive illness. J. Psychosom. Res. 1966; 10: 263
   Google Scholar
• Gibbons J. L., McHugh P. R. Plasma cortisol levels in depressive illness. J. Psychiat. Res. 1962; 1: 162
   PubMed Web of Science ®Google Scholar
• Gibbons J. L., Gibson J. G., Maxwell A. E., Wilcox D. R. C. An endocrine study of depressive illness. J. Psychosom. Res. 1960; 5: 32
   Google Scholar
• Gibbs C. E., Lemeke D. A study of basal metabolism in dementia praecox and manic depressive psychosis. Arch. Int. Med. 1923; 31: 102
   Google Scholar
• Goldman D. Specific electroencephalographic changes with pentothal activation in psychotic states. Electroenceph. Clin. Neurophysiol. 1959; 11: 657
   Google Scholar
• Goldman D. Electroencephalographic manifestations associated with psychotic illness: pentothal activation techniques and pharmacologic interrelationships. Compr. Psychiat. 1964; 5: 80
   Google Scholar
• Gottlieb G., Paulson G., Raleigh N. C. Salivation in depressed patients. Arch. Gen. Psychiat. 1961; 5: 468
   Google Scholar
• Gour K. N., Chaudhry H. M. Study of calcium metabolism in electric convulsive therapy (E.C.T.) in certain mental diseases. J. Ment. Sci. 1957; 103: 275
   Google Scholar
• Green R. Morning and afternoon plasma 17-hydroxycorticosteroid levels during affective psychosis. Int. J. Neurol. Psychiat. 1967; 3: 133
   Google Scholar
• Greenblatt M., Healey M. M., Jones G. A. Age and electroencephalographic abnormality in neuropsychiatric patients. Amer. J. Psychiat. 1944; 101: 82
   Google Scholar
• Greenfield N. S., Katz D., Alexander A. A., Roessler R. The relationship between physiological and psychological responsivity: depression and galvanic skin response. J. Nerv. Ment. Dis. 1963; 136: 535
   Google Scholar
• Grinker R. R., Miller J., Sabshin M., Nunn R., Nunnally J. C. The Phenomena of Depressions. P. B. Hoeber, New York 1961
   Google Scholar
• Grosz H. J., Miller I. Two factors limiting the reliability of the mecholyl test: variability in day-to-day responses and dissimilarity between simultaneous bilateral determinations. J. Nerv. Ment. Dis. 1958; 127: 417
   Google Scholar
• Hackfield A. W. Are physiologic disturbances related to the acute psychotic process in the mentally ill?. Arch. Neurol. Psychiat. 1932; 28: 883
   Google Scholar
• Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiat. 1960; 23: 56
   PubMed Web of Science ®Google Scholar
• Hamilton M., White J. M. Investigation of outcome of treatment of depression. Proc. Roy. Soc. Med. 1959; 52: 583
   Google Scholar
• Hamilton M., White J. M. Clinical syndromes in depressive states. J. Ment. Sci. 1959; 105: 985
   PubMed Web of Science ®Google Scholar
• Hamilton M., White J. M. Factors related to the outcome of depression treated with E.C.T. J. Ment. Sci. 1960; 106: 1031
   Google Scholar
• Hauptmann A., Myerson A. Studies of finger capillaries in schizophrenia and manicdepressive psychoses. J. Nerv. Ment. Dis. 1948; 108: 91
   Google Scholar
• Henneman D. H., Altschule M. D., Goncz R. M. Carbohydrate metabolism in brain disease. Arch. Int. Med. 1954; 94: 402
   Google Scholar
• Henneman D. H., Altschule M. D., Goncz R. M. Carbohydrate metabolism in brain disease. Arch. Neurol. Psychiat. 1954; 72: 696
   Google Scholar
• Henry G. W. Gastrointestinal motor functions in manic-depressive psychoses. Amer. J. Psychiat. 1931; 11: 19
   Google Scholar
• Herrington R. N., Claridge G. S. Sedation threshold and Archimedes spiral after-effect in early psychosis. J. Psychiat. Res. 1965; 3: 159
   Google Scholar
• Hertting G., Axelrod J., Whitby L. G. Effect of drugs on the uptake and metabolism of H3-norepinephrine. J. Pharmacol. Exper. Therap. 1961; 134: 146
   PubMed Web of Science ®Google Scholar
• Hes J. P. H. Manic-depressive psychosis. Electroenceph. Clin. Neurophysiol. 1960; 21: 59
   Google Scholar
• Hippius H., Kanig K. L., Selbach H. Humorale Veranderungen unter psychiatrischer Pharmako-therapie. Med. Exp. 1960; 2: 110
   Google Scholar
• Hirschstein R. The significance of characteristic autonomic nervous system responses in the adjustment, change and outcome in schizophrenia. J. Nerv. Ment. Dis. 1955; 122: 254
   PubMedGoogle Scholar
• Hoagland H., Malamud W., Kaufman I. C. Change in electroencephalogram and in excretion of 17-ketosteroids accompanying electroshock therapy in agitated depressions. Psychosom. Med. 1946; 8: 246
   Google Scholar
• Hopkinson G. A genetic study of affective illness in patients over 50. Brit. J. Psychiat. 1964; 110: 244
   Google Scholar
• Horstmann P. Acta Psychiat. et Neurol. 1951; 16: 69
   Google Scholar
• Hullin R. P., Bailey A. D., McDonald R., Dransfield G. A., Milne H. B. Variations in body water during recovery from depression. Brit. J. Psychiat. 1967; 113: 573
   Google Scholar
• Hullin R. P., Bailey A. D., McDonald R., Dransfield G. A., Milne H. B. Body water variations in manic-depressive psychosis. Brit. J. Psychiat. 1967; 113: 584
   Google Scholar
• Hullin R. P., Bailey A. D., McDonald R., Dransfield G. A., Milne H. B. Variations in 11-hydroxycorticosteroids in depression and manic-depressive psychosis. Brit. J. Psychiat. 1967; 113: 593
   Google Scholar
• Hurst L. A., Mundy-Castle A. G., Beerstecher D. M. The electroencephalogram in manic-depressive psychosis. J. Ment. Sci. 1954; 100: 220
   PubMed Web of Science ®Google Scholar
• Igersheimer W. W., Stevenson J. A. F. Effect of electro-shock on the blood pressure in psychotic patients. Arch. Neurol. Psychiat. 1951; 65: 740
   PubMedGoogle Scholar
• Ingram C. G., Brovens W. G. The reproductibility of the mecholyl test. Brit. J. Psychiat. 1966; 112: 167
   Google Scholar
• Itil T. Pentothal induced changes in E.E.G. as a prognostic index in drug therapy of psychotic patients. Amer. J. Psychiat. 1965; 121: 996
   Google Scholar
• Itil T. Pharmacotherapy of Depression, J. O. Cole, J. R. Wittenborn. Thomas, Springfield 1966
   Google Scholar
• Jenner F. A., Gjessing L. R., Cox J. R., Davies-Jones A., Hullin R. P., Hanna S. M. A manic-depressive psychotic with a persistent forty-eight hour cycle. Brit. J. Psychiat. 1967; 113: 895
   PubMed Web of Science ®Google Scholar
• Kallmann F. J. The genetics of psychoses: an analysis of 1,232 twin index families. Congress Internat. de Psychiat, Paris 1950
   Google Scholar
• Kalow W. Pharmacogenetics. Saunders, Philadelphia 1962
   Google Scholar
• Kaij L. Atypical endogenous psychosis: Report on a family. Brit. J. Psychiat. 1967; 113: 415
   PubMed Web of Science ®Google Scholar
• Kay D. W. K. Observations on the natural history and genetics of old age psychoses. Proc. Roy. Soc. Med. 1959; 52: 791
   PubMedGoogle Scholar
• Kehoe M., Itonside W. Studies on the experimental evocation of depressive responses using hypnosis. Psychochem. Med. 1963; 25: 403
   PubMed Web of Science ®Google Scholar
• Kessell A. 1968, Unpublished review.
   Google Scholar
• Kielholz P. Diagnosis and therapy of depressive states. Acta Psychosomatica No. 1, Documenta Geigy, Basle 1959
   Google Scholar
• Kiloh L. G., Garside R. F. The independence of neurotic depression and endogenous depression. Brit. J. Psychiat. 1963; 109: 451
   PubMed Web of Science ®Google Scholar
• Kinkelin M. Verlauf und Prognose des manisch-depressiven Irreseins. Schwz. Arch. Neurol. Psychiat. 1954; 73: 100
   PubMedGoogle Scholar
• Klein R. Clinical and biochemical investigation in a manic-depressive with short cycles. J. Ment. Sci. 1950; 96: 293
   Google Scholar
• Klein R., Nunn R. F. Clinical and biochemical analysis of a case of manic depressive psychosis showing regular weekly cycles. J. Ment. Sci. 1945; 91: 79
   Google Scholar
• Kline N. S., Sacks W. Relief of depression within one day using an MAO inhibitor with 5-HTP. Amer. J. Psychiat. 1963; 120: 274
   PubMed Web of Science ®Google Scholar
• Kline N. S., Sacks W., Simpson G. M. Further studies on one-day treatment of depression with 5-HTP. Amer. J. Psychiat. 1964; 121: 379
   PubMed Web of Science ®Google Scholar
• Klerman G. L., Schildkraut J. J., Hasenbush L. L., Greenblatt M., Friend G. Clinical experience with dihydroxyphenylalanine (DOPA) in depression. J. Psychiat. Res. 1963; 1: 289
   Web of Science ®Google Scholar
• Knapp M. S., Keane P. M., Wright J. G. Circadian rhythm of plasma 11-hydroxycorticosteroids in depressive illness, congestive heart failure and Cushings' syndrome. Brit. Med. J. 1967; 1: 27
   Google Scholar
• Koppin I. J., Gordon E. K. Metabolism of norepinephrine —H3 released by tyramine and reserpine. J. Pharmac. Exp. Ther. 1962; 138: 351
   Google Scholar
• Koppin I. J., Gordon E. K. Metabolism of administered and drug released norepinephrine-7-H3 in the rat. J. Pharmac. Exp. Ther. 1963; 140: 207
   Google Scholar
• Kretschmer E. Korperbau und Charakter. Springer, Berlin 1921
   Google Scholar
• Kurland H. D. Steroid excretion in depressive disorders. Arch. Gen. Psychiat. 1964; 10: 554
   Google Scholar
• Kurland H. D., Fessel W. J. Distinctive protein patterns in functional psychoses. Proc. Soc. Exp. Biol. Med. 1963; 113: 249
   Google Scholar
• Leonhard K. Aufteilung der Endogenon Psychosen. Akadamia Verlag, Berlin 1959
   Google Scholar
• Lingjaerde O. Failure in utilisation of carbohydrates in mental disease. Acta Psychiat. Neurol. Scand. 1956; 34, Supplement 136
   Google Scholar
• Lingjaerde O. Plasma hydrocortisone in mental diseases. Brit. J. Psychiat. 1964; 110: 423
   PubMed Web of Science ®Google Scholar
• Lockwood M. R. A note on the relationship between the blood cholesterol and hyperglycaemic index in manic-depressive psychosis. J. Ment. Sci. 1932; 78: 901
   Google Scholar
• Loew D. Syndrom, Diagnose und Speichelsekretion bei depressiven Patienten. Psychopharmacologia 1965; 7: 339
   Google Scholar
• Lotsof E. J., Yobst J. Electric shock therapy and the mecholyl test. Psychosom. Med. 1957; 19: 374
   Google Scholar
• Lotsof E. J., Yobst J. The reliability of the mecholyl test. Psychosom. Med. 1957; 19: 370
   Google Scholar
• Lowenstein O., Westphal A. Experimentelle und klinische Studien zur Physiologie und Pathologie der Schizophrenie. Abh. Neurol. Psychiat. Psychol. 1933; 70: 1
   Google Scholar
• Lunde F., Mansfield E., Smith J. A. Mecholyl chloride as a prognostic test in psychiatric patients. J. Nerv. Ment. Dis. 1958; 127: 430
   Google Scholar
• Margeirison J. H., Anderson W. McC., Dawson J., Lettich E. The relationship between sodium metabolism, verbal output and the E.E.G. in depressives. Electroenceph. Clin. Neurophysiol. 1962; 14: 853
   Google Scholar
• Martin I., Davies B. M. Sleep thresholds in depression. J. Ment. Sci. 1962; 108: 466
   Google Scholar
• Martin I., Davies B. M. The effects of sodium amytal on autonomic and muscle activity in patients with depressive illness. Brit. J. Psychiat. 1965; 111: 168
   Google Scholar
• Martin I., Rees L. Reaction times and somatic reactivity in depressed patients. J. Psychosom. Res. 1966; 9: 375
   PubMedGoogle Scholar
• Masters A. B. The distribution of blood groups in psychiatric illness. Brit. J. Psychiat. 1967; 113: 1309
   Web of Science ®Google Scholar
• Michaux M. H., Zwaag L. V., Kurland A. A. Dimensions of manifest depression in newly-hospitalised patients. Brit. J. Psychiat. 1967; 113: 981
   Google Scholar
• Mitsuda H. Klinische-erbbiologische Untersiichung der endogenen Psychosen. Acta Genet. (Basel). 1957; 7: 371
   PubMedGoogle Scholar
• Mitsuda H. The concept of atypical psychoses — from the aspect of clinical genetics. Folia Psychiat. et Neurol. Japonica 1962; 16: 214
   Google Scholar
• Motulsky A. G. The genetics of abnormal drug responses. Ann. N.Y. Acad. Sci. 1965; 123: 167
   PubMed Web of Science ®Google Scholar
• Moody J. P., Tait A. C., Todrick A. Plasma levels of imipramine and desmethylimipramine during therapy. Brit. J. Psychiat. 1967; 113: 183
   PubMed Web of Science ®Google Scholar
• Moriarty J. D., Siemens J. C. Electroencephalographic study of electric shock therapy. Arch. Neurol. Psychiat. 1947; 57: 712
   Google Scholar
• Muller H. F., Kenyon J. Simple indicators of arousal levels in psychiatric treatment situations. Canad. Psychiat. Ass. J. 1965; 10: 51
   Google Scholar
• MacDougall E. J., Stanton J. B., Binns J. K. 5-hydroxy-indole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. Lancet 1966; 2: 1049
   Google Scholar
• McClure D. J. The effects of antidepressant medication on the diurnal plasma cortisol levels in depressed patients. J. Psychosom. Res. 1966; 10: 197
   Google Scholar
• McClure D. J. The diurnal variation of plasma cortisol levels in depression. J. Psychosom. Res. 1966; 10: 189
   PubMed Web of Science ®Google Scholar
• McConaghy N., Joffe A. D., Murphy B. The independence of neurotic and endogenous depression. Brit. J. Psychiat. 1967; 113: 479
   PubMed Web of Science ®Google Scholar
• McFarland R. A., Goldstein H. The biochemistry of manic-depressive psychosis: a review. Amer. J. Psychiat. 1939; 96: 21
   Google Scholar
• McMaster P. D., Franzel R. E. Effects of adrenalcorticoid steroids upon antibody formation. Metabolism 1961; 10: 990
   Web of Science ®Google Scholar
• Nelson R., Gellhorn E. The action of autonomic drugs in normal persons and neuro-psychiatric patients. Psychosom. Med. 1957; 19: 486
   PubMed Web of Science ®Google Scholar
• Neustadt R., Howard L. G. Fluctuations of blood iodine in cyclic psychoses. Amer. J. Psychiat. 1942; 99: 130
   Google Scholar
• Norris A. S., Chowning J. R. Constitutional factors in mental illness. Third World Congress of Psychiatry Proceedings. 1961; 1: 334
   Google Scholar
• Norris A. S., Chowning J. R. Capillary morphology of the nail fold in the mentally ill. J. Neuropsychiat. 1964; 5: 225
   Google Scholar
• Northcote M. L. M. Somatic changes in psychoses: A comprehensive investigation of the bodily functions of 30 psychotic patients by means of clinical, pathological, biochemical, pharmacological and radiological methods. J. Ment. Sci. 1932; 78: 263
   Google Scholar
• Nymgaard K. Studies on sedation threshold. Arch. Gen. Psychiat. 1959; 1: 530
   PubMedGoogle Scholar
• Odegard O. The psychiatric disease entities in the light of a genetic investigation. Acta Psychiat. Scand. 1963; 94, Supplement 169
   Google Scholar
• Oswald I. Biochemical functions involved in the control of sleep and dreaming: a summary. J. Psychosom. Res. 1965; 9: 111
   Google Scholar
• Overall J. E. Dimensions of manifest depression. Psychiat. Res. 1962; 1: 239
   Google Scholar
• Palmai G., Blackwell B. The diurnal patterns of salivary flow in normal and depressed patients. Brit. J. Psychiat. 1965; 111: 334
   PubMedGoogle Scholar
• Palmai G., Blackwell B., Maxwell A. E., Morgenstern F. Patterns of salivary flow in depressive illness and during treatment. Brit. J. Psychiat. 1967; 113: 1297
   Web of Science ®Google Scholar
• Pare C. B. M. Some clinical aspects of antidepressant drugs. The Scientific Aspects of Drug Therapy in Psychiatry, Marks, Pare. Pergamon Press, Oxford 1965
   Google Scholar
• Pare C. B. M., Sandler M. A clinical and biochemical study of a trial of iproniazid in the treatment of depression. J. Neurol. Psychiat. 1959; 22: 247
   PubMed Web of Science ®Google Scholar
• Pare C. B. M., Rees L., Sainsbury M. I. Differentiation of two genetically-specific types of depression by the response to antidepressants. Lancet 1962; 2: 1340
   PubMed Web of Science ®Google Scholar
• Parker J. B., Theilli A., Spielberger C. D. Frequency of blood types in a homogeneous group of manic-depressive patients. J. Ment. Sci 1961; 107: 936
   PubMed Web of Science ®Google Scholar
• Pasquarelli B., Campbell R. J., Polantin P., Hurwitz W. Further appraisal of the adrenalin-mecholyl (Funkenstein) test. Psychosom, Med. 1956; 8: 143
   Google Scholar
• Peck R. E. The SHP test — an aid in the detection and measurement of depression. Arch. Gen. Psychiat. 1959; 1: 35
   Web of Science ®Google Scholar
• Perrin G. M., Altschule M. D., Halliday P. D. Carbohydrate metabolism in brain disease. XIII. Effect of lactate infusion on blood keto-acid concentrations in schizophrenic and manic-depressive psychoses. Arch. Int. Med. 1960; 105: 752
   Google Scholar
• Perry T. L., Hansen S., MacDougal L., Schwartz C. J. Studies of amines in normal and schizophrenic subjects. Amines and Schizophrenia, H. E. Himwich, S. S. Kety, J. R. Smythies. Pergamon Press, Oxford 1967
   Google Scholar
• Pospisilova V., Janik A. The relationship of the blood serum protein fractions to the clinical picture in psychoses and psychotic states, determined by paper electrophoresis. Rev. Czech. Med. 1958; 4: 29
   Google Scholar
• Praag H. M., Van Leijnse B. Die Bedeutung der Monoaminoxydasehemmung aes antidepressive Prinzip. I. Psychopharmacologia. (Berlin) 1963; 4: 1
   Google Scholar
• Praag H. M., Van Leijnse B. The influence of some antidepressives of the hydrazine type on the glucose metabolism in depressed patients. Clin. Chem. Acta. 1963; 8: 466
   Google Scholar
• Praag H. M., Van Leijnse B. Depression, glucose tolerance, peripheral glucose uptake and their alterations under the influence of anti-depressive drugs of the hydrazine type. Psycho-pharmacologia 1965; 8: 67
   Google Scholar
• Praag H. M., Van Leijnse B. Some aspects of the metabolism of glucose and of the non-esterified fatty acids in depressive patients. Psychopharmacologia 1966; 9: 220
   Google Scholar
• Proctor L. D., Goodwin F. E. Clinical and electrophysiological observations following electroshock. Amer. J. Psychiat. 1943; 101: 791
   Google Scholar
• Pryce I. G. Melancholia, glucose tolerance and body weight. J. Ment. Sci. 1958; 104: 421
   Google Scholar
• Pryce I. G. The relationship between glucose tolerance, body weight and clinical state in melancholia. J. Ment. Sci. 1958; 104: 1079
   Google Scholar
• Pryce I. G. The relationship between 17-hydroxycorticosteroid excretion and glucose utilisation in depression. Brit. J. Psychiat. 1964; 110: 90
   PubMed Web of Science ®Google Scholar
• Quadbeck G. The influence of psychotropic drugs on the blood-brain barrier in animal experiments. Proc. Third World Congress Psychiatry. Montreal 1961; 2: 911
   Google Scholar
• Quadbeck G., Sachsse W. Arch. Psychiat. Nervenk. 1961; 201: 580
   Google Scholar
• Rees W. L. Physical constitution, neurosis and psychosis. Proc. Roy. Soc. Med. 1944; 37: 35
   Google Scholar
• Rees W. L. Body build, personality and neurosis in women. J. Ment. Sci. 1950; 96: 426
   PubMed Web of Science ®Google Scholar
• Rees L. Constitutional factors in abnormal behaviour. Handbook of Abnormal Psychiatry, H. J. Eysenck. Pitman Medical Publishing Co. Ltd, London 1960
   Google Scholar
• Reiss M., Hemphill R. E., Gordon J. J., Cook E. R. Regulation of urinary steroid excretion. 2. Spontaneous changes in the pattern of daily excretion in mental patients. Biochem. J. 1949; 45: 574
   Google Scholar
• Rey J. H., Coppen A. Distribution of androgyny in a psychiatric population. Brit. Med. J. 1959; 2: 1445
   PubMed Web of Science ®Google Scholar
• Rimon R., Stenback A., Huhmar E. Electromyographic findings in depressive patients. J. Psychosom. Res. 1966; 10: 159
   Google Scholar
• Roberts J. L. Prognostic factors in the electroshock treatment of depressive states. J. Ment. Sci. 1959; 105: 69
   Google Scholar
• Roberts J. L. Prognostic factors in the electroshock treatment of depressive states. II. The application of specific tests. J. Ment. Sci. 1959; 105: 703
   PubMed Web of Science ®Google Scholar
• Rodnight R. Body fluid indoles in mental illness. Internat. Rev. Neurobiol. 1961; 3: 251
   Google Scholar
• Roll A., Entres J. L. Zum Problem der Erbprognosebestimmung. Ztschr, ges Neurol, u. Psychiat. 1936; 156: 169
   Google Scholar
• Rose J. T. Autonomic function in depression. J. Ment. Sci. 1962; 108: 624
   Google Scholar
• Rosenblatt S., Chanley J. D. Differences in the metabolism of norepinephrine in depression. Arch. Gen. Psychiat. 1965; 13: 495
   Google Scholar
• Rosenthal S. H., Gudeman J. E. The endogenous depressive pattern. Arch. Gen. Psychiat. 1967; 16: 241
   PubMed Web of Science ®Google Scholar
• Rosenthal S. H., Gudeman J. E. The self-pitying constellation in depression. Brit. J. Psychiat. 1967; 113: 485
   Google Scholar
• Rosenthal S. H., Klerman G. L. Content and consistency in the endogenous depressive pattern. Brit. J. Psychiat. 1966; 112: 471
   Web of Science ®Google Scholar
• Rosenthal S. H., Klerman G. L. Endogenous features of depression. Canad. Ass. Psychiat. J. 1966; 11, Supplement
   Google Scholar
• Roth M. Changes in the E.E.G. under barbiturate anaesthesia produced by electroconvulsive treatment and their significance for the theory of E.C.T. action. Electroenceph. Clin. Neurophysiol. 1951; 3: 261
   PubMedGoogle Scholar
• Roth M., Garside R. S., Gurney C. Clinical-statistical enquiries into the classification of anxiety states and depressive disorders. Proceedings of the Leeds Symposium on Behavioural Disorders, F. A. Jenner. May and Baker, England 1965; 175
   Google Scholar
• Roth M., Kay D. W. K., Shaw J., Green J. Prognosis and pentothal induced electro-encephalographic changes in electroconvulsive therapy. Electroenceph. Clin. Neurophysiol. 1957; 9: 225
   PubMedGoogle Scholar
• Rowntree D. W., Nevin S., Wilson A. The effects of diisopropylfluorophosphonate in schizophrenia and manic-depressive psychosis. J. Neurol, Neurosurg. Psychiat. 1950; 13: 47
   PubMed Web of Science ®Google Scholar
• Russell G. F. M. Body weight and balance of water, sodium and potassium in depressed patients given electroconvulsive therapy. Clin. Sci. 1960; 19: 327
   Google Scholar
• Satterfield J. H. Prediction of improvement by the use of epinephrine — methacholine (mecho-lyl) test. Arch. Neurol. Psychiat. 1959; 81: 513
   Google Scholar
• Sakai M. Diurnal rhythm of 17-ketosteroids and diurnal fluctuation of depressive affect. Yokohama Med. Bull. 1960; 11: 352
   Google Scholar
• Schildkraut J. J., Gordon E. K., Durell J. Catecholamine metabolism in affective disorders: I. J. Psychiat. Res. 1965; 3: 213
   PubMed Web of Science ®Google Scholar
• Schildkraut J. J., Klerman G. L., Friend D. G., Greenblatt M. Biochemical and pressor effects of oral DL-dehydroxyphenylalanine (dopa) in depression. J. Psychiat. Res. 1963; 1: 289
   Google Scholar
• Schildkraut J. J., Gordon E. K., Hammond R., Friend D. G. Excretion of 3-methoxy-4-hydroxymandelic acid (VMA) in depressed patients treated with antidepressant drugs. J. Psychiat. Res. 1964; 2: 257
   Google Scholar
• Shagass C. Prediction of improvement by the use of epineprine-methacholine (mecholyl) test. Arch. Neurol. Psychiat. 1954; 81: 513
   Google Scholar
• Shagass C. Differentiation between anxiety and depression by the photically-activated electroencephalogram. Amer. J. Psychiat. 1955; 112: 41
   Google Scholar
• Shagass C., Jones A. L. A neurophysio-logical test for psychiatric diagnosis: results in 750 patients. Amer. J. Psychiat. 1958; 114: 1002
   PubMed Web of Science ®Google Scholar
• Shagass C., Kerenyi A. B. The 'sleep' threshold. A simple form of the sedation threshold for clinical test. Canad. Psychiat. Ass. J. 1958; 3: 101
   Google Scholar
• Shagass C., Naiman J. The sedation threshold, manifest anxiety and some aspects of ego function. Arch. Neurol. Psychiat. 1955; 74: 397
   Google Scholar
• Shagass C., Naiman J. The sedation threshold as an objective index of manifest anxiety in psychoneurosis. J. Psychosom. Res. 1955; 1: 49
   Google Scholar
• Shagass C., Schwartz M. Evoked cortical potentials and sensation in man. J. Neuro-psychiat. 1961; 2: 262
   Google Scholar
• Shagass C., Schwartz M. Cerebral cortical reactivity in psychotic depressions. Arch. Gen. Psychiat. 1962; 6: 67
   Google Scholar
• Shagass C., Schwartz M. Psychiatric correlates of evoked cerebral cortical potentials. Amer. J. Psychiat. 1963; 119: 1055
   PubMed Web of Science ®Google Scholar
• Shagass C., Schwartz M. Visual cerebral evoked response characteristics in a psychiatric population. Amer. J. Psychiat. 1965; 121: 979
   Google Scholar
• Shagass C., Schwartz M. Somatosensory cerebral evoked responses in psychotic depression. Brit. J. Psychiat. 1966; 112: 799
   PubMedGoogle Scholar
• Shagass C., Muller K., Acosta H. B. The pentothal 'sleep' threshold as an indicator of affective change. J. Psychosom. Res. 1959; 3: 253
   Google Scholar
• Shagass C., Naiman J., Milhalik J. An objective test which differentiates between neurotic and psychotic depression. Arch. Neurol. Psychiat. 1956; 75: 461
   Google Scholar
• Shaw D. M., Coppen A. Potassium and water distribution in depression. Brit. J. Psychiat. 1966; 112: 269
   Google Scholar
• Shaw D. M., Camps F. E., Eccleston E. G. 5-hydroxytryptamine in the hind-brain of depressive suicides. Brit. J. Psychiat. 1967; 113: 1407
   PubMed Web of Science ®Google Scholar
• Sheldon W. H. The Varieties of Human Physique. Harper, New York 1940
   Google Scholar
• Sheldon W. H. The Varieties of Temperament. Harper, New York 1942
   Google Scholar
• Shinfuku N. Clinical and biochemical studies with antidepressants. Yonago Acta Medica. 1965; 9: 100
   Google Scholar
• Sigg E. B. Pharmacological studies with tofranil. Canad. Psychiat. Assoc. J. 1959; 75, Supplement
   Google Scholar
• Sigg E. B. The pharmacodynamics of imipramine. Psychosomatic Medicine, J. H. Nodine, J. H. Meyer. Lea and Fibiger, Philadelphia 1962
   Google Scholar
• Sita B., Mowrer M., Ulett G., Johnson M. The differentiation of psychiatric patients by E.E.G. changes after sodium pentothal. Recent Advances in Biological Psychiatry, J. Wortis. Plenum Press, New York 1962; 4: 191
   Google Scholar
• Sjögren T. Genetic-statistical and Psychiatric Investigations of a West Swedish Population. Acta Psychiat., Kbh. 1948, Supplement 32
   Google Scholar
• Skottowe I. Somatometry — a second look. Brit. J. Psychiat. 1965; 111: 1
   Google Scholar
• Slater E. Zur Periodik des manisch-depressiven Irreseins. Z. ges Neurol. Psychiat. 1938; 152: 794
   Google Scholar
• Slater E., Slater P. A neurotic theory of neurosis. J. Neurol. Neurosurg. Psychiat. 1944; 7: 49
   PubMedGoogle Scholar
• Sloane R. B., Lewis D. J. Prognostic value of adrenalin and mecholyl responses in electroconvulsive therapy. J. Psychosom. Res. 1956; 1: 273
   Google Scholar
• Sloane R. B., Hughes W., Haust H. L. Catecholamine excretion in manic-depressive and schizophrenic psychosis and its relationship to symptomatology. Canad. Psychiat. Assoc. J. 1966; 11: 6
   Google Scholar
• Sloane R. B., Lewis D. J., Slater P. Diagnostic value of blood pressure responses in psychiatric patients. Arch. Neurol. Psychiat. 1957; 77: 540
   Google Scholar
• Sloane R. B., Habib A., Eveson M. B., Payne R. W. Some behavioural and other correlates of cholesterol metabolism. J. Psychosom. Res. 1961; 5: 183
   Google Scholar
• Smith B., Prockop D. J. Central nervous system effects of injection of L-tryptophan by normal subjects. New England J. Med. 1962; 267: 1338
   Google Scholar
• Smith B., Simon A., Lingces J. C. Excretion of urinary corticoids in mental patients. J. Nerv. Ment. Dis. 1956; 124: 381
   Google Scholar
• Sourkes T. L. Biochemistry of Mental Disease. Hoeber Medical Division, Harper and Row, New York 1962
   Google Scholar
• Speck L. B., Dim B., Mercer M. Visual evoked responses in psychiatric patients. Arch. Gen. Psychiat. 1966; 15: 59
   Google Scholar
• Spooner C. E. Comparison of averaged auditory evoked responses during spontaneous monoamine induced states of wakefulness and sleep in the chick. Federation Proceedings 1965; 24: 135
   Google Scholar
• Stemmerman M. G., Owen T. V. Serial autonomic testing in psychiatric disorders. J. Clin. Exp. Psychopath. 1957; 18: 236
   Google Scholar
• Stenback A., Jakobson T., Rimon R. Depression and anxiety ratings in relation to the excretion of urinary total 17-OHCS in depressive subjects. J. Psychosom. Res. 1966; 9: 355
   Google Scholar
• Stenstedt A. A study in manic-depressive psychosis. Acta Psychiat. et Neurol. 1952, Supplement 79
   Google Scholar
• Stenstedt A. Involutional melancholia. Acta Psychiat. et Neurol. 1959, Supplement 127
   Google Scholar
• Stenstedt A. Genetics of neurotic depression. Acta Psychiat. Scand. 1966; 42: 392
   PubMed Web of Science ®Google Scholar
• Tsuang M. A study of pairs of sibs both hospitalised for mental disorder. Brit. J. Psychiat. 1967; 113: 283
   PubMed Web of Science ®Google Scholar
• Tucker G. T., Detre T., Harrow M., Glaser G. H. Behaviour and symptoms of psychiatric patients and the electroencephalogram. Arch. Gen. Psychiat. 1965; 12: 278
   Google Scholar
• Vernier V. G. The pharmacology of antidepressant agents. Dis. Nerv. Syst. 1961; 22: 7
   Google Scholar
• Vogt M. Catecholamines in the brain. Pharmac. Rev. 1959; 11: 483
   PubMed Web of Science ®Google Scholar
• Weckowicz T. E. Reliability of the mecholyl test. Arch. Neurol. Psychiat. 1956; 76: 109
   Google Scholar
• Weil A. A., Brineger W. C. Electro-encephalographic studies following electric shock therapy. Arch. Neurol. Psychiat. 1947; 57: 719
   PubMedGoogle Scholar
• Whatmore G. B., Ellis R. M. Some neurophysiologic aspects of depressed states. Arch. Gen. Psychiat. 1959; 1: 70
   Google Scholar
• Whatmore G. B., Ellis R. M. Further neurophysiologic aspects of depressed states. Arch. Gen. Psychiat. 1962; 6: 243
   Google Scholar
• Wilson W. P., Wilson N. J. Observations on the duration of photically-elicited arousal responses in depressive psychoses. J. Nerv. Ment. Dis. 1961; 133: 438
   Google Scholar
• Winnik H. Z., Assael M. Endogenous depression with reversible E.E.G. findings. Israel. Ann. Psychiat. Rel. Disc. 1966; 4: 91
   Google Scholar
• Winnik H. Z., Clayton P. Family history studies. I. Two types of affective disorders separated according to genetic and clinical factors. Recent Advances in Biological Psychiatry, J. Wortis. Plenum Press, New York 1967; Vol. 9
   Google Scholar
• Winokur G., Pitts J. F. N. Affective disorder: VI. A family history study of prevalences, sex differences and possible genetic factors. J. Psychiat. Res. 1965; 3: 113
   PubMed Web of Science ®Google Scholar
• Wittman P., Sheldon W. H., Katz C. J. A study of the relationships between constitutional variations and fundamental psychotic behaviour reactions. J. Nerv. Ment. Dis. 1948; 108: 470
   Google Scholar
• Wolberg L. R. Basal metabolism in manic-depressive psychosis. Psychiat. Quart. 1935; 9: 586
   Google Scholar
• Woodruff R. The diagnostic use of the amylobarbitone interview among patients with psychotic illness. Brit. J. Psychiat. 1966; 112: 727
   Google Scholar
• Woodruff R., Jr., Pitts F. N., Winokur G. Affective disorder: II. A comparison of patients with and without family history of affective disorder. J. Nerv. Ment. Dis. 1964; 139: 49
   Google Scholar